Aura Biosciences (NASDAQ:AURA) Receives Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Aura Biosciences (NASDAQ:AURA – Free Report) in a research note released on Thursday morning,Benzinga reports. HC Wainwright currently has a $22.00 price target on the stock. A number of other research analysts have also recently commented on the company. Cowen reissued a “buy” rating on shares […]
More Stories
MultiMetaVerse Holdings Limited (NASDAQ:MMV) Short Interest Down 18.3% in October
MultiMetaVerse Holdings Limited (NASDAQ:MMV – Get Free Report) was the recipient of a large decrease in short interest during the...
Short Interest in Gentherm Incorporated (NASDAQ:THRM) Decreases By 18.7%
Gentherm Incorporated (NASDAQ:THRM – Get Free Report) was the target of a significant decline in short interest during the month...
Zillow Group, Inc. (NASDAQ:ZG) General Counsel Sells $134,813.38 in Stock
Zillow Group, Inc. (NASDAQ:ZG – Get Free Report) General Counsel Bradley D. Owens sold 1,846 shares of the company’s stock...
Short Interest in TruGolf Holdings, Inc. (NASDAQ:TRUG) Drops By 19.0%
TruGolf Holdings, Inc. (NASDAQ:TRUG – Get Free Report) was the recipient of a large drop in short interest in October....
Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Update
Aspira Women’s Health Inc. (NASDAQ:AWH – Get Free Report) was the target of a significant growth in short interest in...
Beneficient (NASDAQ:BENFW) Short Interest Up 23.3% in October
Beneficient (NASDAQ:BENFW – Get Free Report) was the recipient of a large growth in short interest during the month of...